Jun 17, 2019 - Big Ticket Mergers Are in Focus
Jun 14, 2019 - FDA approves Amgen (AMGN) and Allergan's Kanjiniti, a biosimilar version of Roche's (RHHBY) breast cancer drug, Herceptin.
Jun 12, 2019 - Novartis (NVS) announces new data on psoriatic arthritis drug, Cosentyx.
Jun 12, 2019 - Top Ranked Income Stocks to Buy for June 12th
Jun 12, 2019 - Merck's (MRK) Keytruda is already approved for use in 15 cancer indications across 10 different tumor types in the United States.
Jun 12, 2019 - The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.
Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Jun 06, 2019 - Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft
Jun 06, 2019 - America's largest pharmaceutical company had plenty of good reasons not to pursue a potential new Alzheimer's treatment.
Jun 05, 2019 - Blueprint Medicines' (BPMC) excessive confidence in partners for revenue recognition is still a huge cause for concern.